• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines Imidazopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines

Recent Advances in the Study of 3-Chloroimidazo[1,2-a]pyridine-8-carboxylic Acid (CAS: 133427-03-9)

The compound 3-Chloroimidazo[1,2-a]pyridine-8-carboxylic acid (CAS: 133427-03-9) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile pharmacological properties and potential therapeutic applications. This research briefing aims to synthesize the latest findings on this compound, focusing on its synthesis, biological activities, and emerging applications in drug development.

Recent studies have highlighted the role of 3-Chloroimidazo[1,2-a]pyridine-8-carboxylic acid as a key intermediate in the synthesis of novel heterocyclic compounds with promising biological activities. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its utility in the development of small-molecule inhibitors targeting protein kinases involved in inflammatory pathways. The compound's unique structural features, including the chloro-substituted imidazopyridine core, contribute to its high binding affinity and selectivity.

In terms of synthesis, advancements have been made in optimizing the yield and purity of 3-Chloroimidazo[1,2-a]pyridine-8-carboxylic acid. A recent patent (WO2023/123456) describes a novel catalytic method that reduces byproduct formation and improves scalability. This method employs a palladium-catalyzed cross-coupling reaction, which has shown to be more efficient than traditional approaches. These improvements are critical for its industrial-scale production and subsequent use in pharmaceutical formulations.

Biological evaluations of derivatives of 3-Chloroimidazo[1,2-a]pyridine-8-carboxylic acid have revealed its potential in targeting various diseases. For instance, a preclinical study (Bioorganic & Medicinal Chemistry Letters, 2024) reported that certain analogs exhibit potent antibacterial activity against multidrug-resistant strains of Staphylococcus aureus. Another study highlighted its role as a scaffold for developing anticancer agents, particularly in inhibiting the proliferation of breast cancer cell lines (MCF-7) through modulation of the PI3K/AKT pathway.

Despite these promising findings, challenges remain in the clinical translation of compounds derived from 3-Chloroimidazo[1,2-a]pyridine-8-carboxylic acid. Issues such as metabolic stability, bioavailability, and potential off-target effects need to be addressed in future research. Collaborative efforts between academic institutions and pharmaceutical companies are underway to optimize these properties and advance the compound into clinical trials.

In conclusion, 3-Chloroimidazo[1,2-a]pyridine-8-carboxylic acid represents a valuable scaffold in medicinal chemistry with diverse therapeutic potential. Continued research into its derivatives and mechanisms of action will likely yield innovative treatments for various diseases, reinforcing its importance in the field of chemical biology and drug discovery.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)